Plasma Half-Life
Plasma Half-Life — The time for plasma concentration of a peptide to decrease by 50%, determining dosing frequency in preclinical research protocols.
What Is Plasma Half-Life?
Plasma half-life is the time for the plasma concentration of a peptide to decrease by 50%, measured by serial blood sampling and LC-MS/MS or immunoassay quantification. Plasma half-life is the most clinically relevant PK parameter, directly determining dosing frequency and patient convenience.
Measurement
- Protocol: IV or SC dose, serial blood draws over 5+ half-lives, quantify peptide at each time point
- Analysis: Non-compartmental (NCA) or compartmental PK modeling
- Extension goal: Transform minutes (native) to hours/days/weeks (modified) for practical dosing
Frequently Asked Questions
What is Plasma Half-Life?
The time for plasma concentration of a peptide to decrease by 50%, determining dosing frequency in preclinical research protocols.
Why is Plasma Half-Life important in peptide research?
Plasma Half-Life is a fundamental concept in pharmacology as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.
Authority Sources
- Plasma Half-Life on Wikipedia
- Search Plasma Half-Life on PubChem (NIH)
- Research articles on ScienceDirect